The Week in Review: Jinhe Biotech Stages $79 Million IPO in Shenzhen
03:43 EDT 22 Jul 2012 | ChinaBio Today
Jinhe Biotechnology of Inner Mongolia raised $78.6 million in an IPO on the Shenzhen’s SME Exchange; Tianjin Joint Academy of Biotechnology and Medicine (TJAB) formed a JV with Australia’s Antisense Therapeutics to develop ANP’s..
Original Article: The Week in Review: Jinhe Biotech Stages $79 Million IPO in Shenzhen
More From BioPortfolio on "The Week in Review: Jinhe Biotech Stages $79 Million IPO in Shenzhen"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
